Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News

    Byju's EGM begins: Raveendran skips, investors file suit before the NCLT


    Finance Outlook India Team | Friday, 23 February 2024

    On Friday, an Extraordinary General Meeting (EGM) of Byju's shareholders began to vote on a resolution proposed by some investors to remove founder CEO Byju Raveendran and his family for alleged "mismanagement and failures".

    Raveendran and his family refused to attend the EGM, claiming it was "procedurally invalid." Ahead of the EGM, a group of four Byju's investors filed an oppression and mismanagement suit against the company's management in the NCLT's Bengaluru bench on Thursday evening, seeking the declaration of founders, including CEO Byju Raveendran, as unfit to run the company, the appointment of a new board, the voiding of the recently concluded rights issue, and a forensic audit of accounts.

    According to sources with firsthand knowledge of the situation, the EGM was scheduled to begin at 0930 hours on Friday morning but was delayed by about an hour as approximately 200 persons, some of whom are Byju employees, attempted to attend the virtual meeting.

    Only after proper verification were the investors escorted in, they said, adding that some 40 people representing the investors were permitted in and will vote on the resolution proposed by some of them.

    However, the decision of the EGM vote will not be valid until March 13, when the Karnataka High Court will hear Raveendran's appeal against the request by certain investors.

    The High Court on Wednesday refused to halt the EGM, which was called by shareholders who collectively own more than 32% of Byju's. Raveendran and his family hold 26.3 percent of the corporation.

    The EGM notification demands for the removal of the present board of Think & Learn, the company that manages Byju's, which includes Raveendran, his wife and co-founder Divya Gokulnath, and his brother Riju Raveendran.

    Byju Raveendran, for his part, wrote to shareholders for the second time in a week, saying the EGM was "procedurally invalid, contractually in contravention" of the articles of association and shareholder agreement, "legally on the wrong side of the Companies Act, 2013, and fundamentally designed and timed to create a media circus around it".

     



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us